Arrowhead Pharmaceuticals
ARWR
#2176
Rank
โ‚น763.11 B
Marketcap
โ‚น5,520
Share price
-4.98%
Change (1 day)
192.28%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): -โ‚น104.69

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น112.30. In 2024 the company made an earnings per share (EPS) of -โ‚น449.18 a decrease over its 2023 EPS that were of -โ‚น171.85.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น104.69-76.69%
2024-โ‚น449.18161.39%
2023-โ‚น171.8517.36%
2022-โ‚น146.4319.85%
2021-โ‚น122.1861.9%
2020-โ‚น75.46-216.67%
2019โ‚น64.68-210.77%
2018-โ‚น58.3938.3%
2017-โ‚น42.22-64.93%
2016-โ‚น120.38-16.25%
2015-โ‚น143.7428%
2014-โ‚น112.30-3.85%
2013-โ‚น116.79-31.58%
2012-โ‚น170.69331.82%
2011-โ‚น39.53-51.11%
2010-โ‚น80.85-79.07%
2009-โ‚น386.30-37.68%
2008-โ‚น619.87-16.87%
2007-โ‚น745.6438.33%
2006-โ‚น539.02122.22%
2005-โ‚น242.5642.11%
2004-โ‚น170.69533.33%
2003-โ‚น26.95-99.08%
2002-โ‚น2,91725%
2001-โ‚น2,33333.33%
2000-โ‚น1,750-120%
1999โ‚น8,750-400%
1998-โ‚น2,917-81.48%
1997-โ‚น15,751

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Alnylam Pharmaceuticals
ALNY
โ‚น8.09-107.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น214.71-291.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-โ‚น258.73 130.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น937.84-935.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-โ‚น724.98 545.60%๐Ÿ‡บ๐Ÿ‡ธ USA